Kishen Patel
Founder, Consult EFC | ICAEW Chartered Accountant
Kishen is an ICAEW Chartered Accountant with over 12 years of experience across Big Four audit, investment banking, and corporate advisory. He works with healthcare and professional services business owners on dental practice valuations and EBITDA-based deal structuring, helping principals understand what drives their achievable price before they engage buyers or advisers.
Valuing a Dental Practice: Why Recurring Patient Revenue Drives Price
Buyers pay more for income they believe will still be there after completion. That is the plain truth behind most dental practice valuations in 2026. If you are thinking about valuing a dental practice, understanding what buyers actually focus on will matter far more than any online calculator.
Many principals look at turnover first. Buyers rarely do. They focus on maintainable EBITDA, risk, and how dependable future income looks once the seller has gone. In the current UK market, dental practice values often sit in a range of 5x to 10x or above EBITDA, depending on whether the practice is primarily NHS, mixed, or private. Strong patient retention can push value toward the upper end because it makes earnings easier to trust.
If you want to grow value before a sale, investment round, or exit, recurring patient revenue deserves your attention first.
How Buyers Really Value a Dental Practice in 2026
Most serious buyers start with adjusted EBITDA, sometimes called normalised EBITDA. They take reported profit and strip out items that do not reflect the true ongoing earnings of the practice: personal costs run through the business, one-off expenses, and owner pay that sits above or below market rate.
Turnover still matters, but it is no longer the primary shortcut. A practice with £1.2 million of revenue and weak margins may be worth less than a practice with £950,000 of revenue and cleaner, stronger profits. Buyers care about cash flow because debt repayment, reinvestment, and future return all come out of that number.
As of April 2026, broad UK market ranges typically look like this:
| Practice Type | Indicative EBITDA Multiple | Key Factors |
|---|---|---|
| Mainly NHS | 5.0x to 8.0x | Contract performance, local demand, margin quality |
| Mixed | 6.0x to 9.0x | Balance of NHS base and private upside, associate structure |
| Predominantly private | 7.0x to 10.0x+ | Retention rate, fee quality, hygiene uptake, recall discipline |
Those are not fixed rules. Size, location, contract quality, patient mix, associate structure, and compliance all affect the outcome. Still, one factor appears consistently across deal types: stable recurring revenue lowers risk, and lower risk supports a stronger multiple. You can explore how earnings multiples work across other sectors in the Valuation Insights Vault.
Why EBITDA Matters More Than Headline Revenue
Two practices can post similar gross fees and end up with very different valuations. The difference often sits in profit quality.
One principal may run personal costs through the business. Another may pay themselves below market rate, which makes profit look better than it truly is. A third may have faced a one-off hit such as flood damage, legal costs, or a significant software change. Buyers adjust for all of these items to reach a fair view of ongoing earnings.
That process matters because clean EBITDA tells a better story than gross fees. It also reveals how much of the profit depends on the principal personally. If the owner delivers most of the dentistry, holds key patient relationships, and controls referrals, the buyer sees higher transfer risk and adjusts the price accordingly.
A practice with stronger retention, better systems, and less owner dependence usually earns a better valuation, even where turnover is similar. The same principle applies to any SME business valuation: earnings quality almost always matters more than headline revenue.
Why Valuation Multiples Differ Across NHS, Mixed, and Private Practices
Practice type shapes risk and growth potential, so it shapes the multiple too.
NHS income can attract buyers because contracts may offer a dependable base. In England, contract reform from April 2026 has kept attention on how predictable NHS income will be, particularly in well-run mixed practices. That does not mean every NHS practice earns a premium: contract performance, local demand, and margin still determine the outcome.
Mixed practices often appeal to a wider buyer pool. They combine a steady NHS base with private upside, which can make earnings feel balanced and scalable for an acquirer.
Private practices can achieve the highest multiples, but only when income is genuinely repeatable. Loyal patients, healthy fees, good hygiene uptake, and a well-managed recall system matter far more than a recent surge in new enquiries or a recently refurbished reception.
Not sure how your practice type affects your achievable multiple?
NHS, mixed, and private practices are valued differently, and the gap between a weak and a strong multiple can be significant. Our Exit Readiness Scorecard identifies the specific value gaps in your practice before buyers do.
- Five-minute diagnostic, instant score
- Covers earnings quality, owner dependence, and recurring income
- 100 per cent confidential, no obligation
Why Recurring Patient Revenue Is the Key Driver of Value
Recurring patient revenue is the income that comes back with reasonable consistency: regular exams, hygiene visits, patient plan income, capitation income, and repeat treatment from an active, returning patient base.
A buyer is not only purchasing chairs, equipment, and last year’s accounts. They are buying confidence in next year’s cash flow. If a large proportion of income comes from returning patients who attend recalls, accept treatment, and stay with the practice over time, future revenue becomes far easier to forecast.
That predictability supports the rest of the business. Staffing becomes easier to plan. Chair utilisation becomes steadier. Marketing spend can stay under control because the practice is not forced to replace lost patients every month.
Recurring revenue also improves profit quality. It typically costs less to retain an existing patient than to acquire a new one. Repeat income therefore often carries stronger margins than revenue driven by constant new patient generation. This is why recurring patient revenue frequently drives more value than a short burst of growth, however impressive that growth may look on paper.
Predictable Income Lowers Risk for a Buyer
Risk sits at the centre of every dental practice deal. The more uncertain the post-sale picture, the lower the price tends to be.
Repeat visits reduce that uncertainty. If recall attendance is high, hygiene demand is consistent, and plan income renews month after month, a buyer can model future cash flow with more confidence. Lenders think the same way, because debt service depends on stable, repeatable earnings.
A reliable patient base also softens the effect of change. New ownership, associate turnover, or local competition may significantly hurt a practice that relies on one-off high-value cases. A practice with strong recurring income often absorbs those shocks better. This is one reason well-run mixed and private practices with disciplined recall systems frequently command stronger multiples.
Patient Retention Is Often More Valuable Than a Spike in New Patients
New patients matter, and growth matters too. Yet buyers are often more impressed by retention than by a temporary jump in first-time bookings.
A surge in new cases can flatter revenue for a period. If those patients do not return, the boost fades quickly. In contrast, a stable active list keeps producing exams, hygiene visits, treatment plans, and referrals over time, at a far lower acquisition cost.
Long-term patients also tend to trust the practice more, so treatment acceptance improves. That creates follow-on income without the same marketing overhead. For valuation purposes, an active, returning patient base is consistently more attractive than short-term growth metrics.
The Numbers That Prove Recurring Revenue Is Real
Good recurring revenue is not a story you tell in a meeting. It is a pattern that shows up in the data. Buyers and their advisers will test whether income is repeatable, transferable, and well documented. If the evidence is weak, they will lower the multiple or challenge your EBITDA adjustments.
| Metric | What It Shows | Why Buyers Care |
|---|---|---|
| Active patient numbers | Size of the current base | A larger, engaged base gives more dependable income |
| Annual retention rate | How many patients stay year on year | High retention lowers revenue risk materially |
| Recall attendance rate | Whether patients return on time | Strong recall improves forecast quality |
| Hygiene revenue share | Repeat care and preventive demand | Good hygiene income often supports stable margin |
| Patient plan or capitation income | Contracted recurring cash flow | Monthly income improves cash flow visibility |
| Reappointment rate | Patient behaviour after each visit | Strong habits reduce diary gaps and lost income |
| Treatment acceptance rate | Conversion from diagnosis to care | Supports future revenue without extra acquisition cost |
| Revenue concentration | Spread across the patient base | Lower reliance on a few patients reduces transaction risk |
Hygiene revenue deserves particular attention. In many practices it is a reliable indicator of recurring engagement: it shows patients return regularly, not only when they have pain or need a larger course of treatment. A healthy hygiene column is one of the clearest signals of a loyal, active patient base.
What Weakens Value Even When Revenue Looks Strong
Some practices produce good revenue but still disappoint during a sale process. Understanding these weaknesses early gives you time to address them.
- Owner dependence: if the principal delivers most of the clinical work and holds key patient relationships, transfer risk rises and the multiple falls
- Poor data quality: buyers cannot verify retention or patient behaviour if reporting is patchy or incomplete
- Unstable associate cover: raises concerns about continuity after completion and may delay lending decisions
- High staff turnover: patients notice team changes, and buyers assume more disruption ahead
- Weak lease terms: limits lending options and makes future site control less secure
- Compliance concerns: CQC issues can delay deals or alter their economics entirely
- Revenue concentrated in large one-off cases: buyers will question how much of that income realistically repeats
Ready to understand what your dental practice is genuinely worth?
Consult EFC prepares ICAEW-grade valuations for healthcare and professional services businesses across the UK, using DCF, EBITDA multiples, and comparable transaction analysis. Every report is prepared personally by Kishen Patel.
- Normalised EBITDA and add-back review for dental practices
- Sector-calibrated multiple analysis: NHS, mixed, and private
- Reports built to withstand buyer, lender, and HMRC scrutiny
- 7 to 10-day turnaround for most engagements
How to Increase Dental Practice Value Before a Sale
If you plan to sell within the next 12 to 24 months, value-building starts now. The goal is to grow repeat income and make it clearly transferable to a new owner. That means improving both the economics of the practice and the quality of the evidence behind them.
Build a Recurring Revenue Base That Can Transfer
Start with recall. A well-managed recall system lifts attendance, keeps diaries fuller, and brings patients back before treatment needs become urgent. Hygiene scheduling matters for the same reason: empty hygiene columns often point to weak retention and will be noticed immediately in due diligence.
Patient plans can help too, if managed well. Regular monthly income improves cash flow visibility and keeps patients engaged between treatments. Even without formal plans, stronger reappointment habits across the practice can materially lift recurring revenue.
At the same time, reduce dependence on the principal. Broaden the associate-led model where possible. Make introductions between patients and other clinicians part of the standard patient journey. Build a team structure that does not rely on one person to hold the practice together. This is where many principals lose value without realising it: a buyer will pay more for income that will continue after the seller steps back.
Get Your Financial and Operational Data Sale-Ready
Clean reporting helps buyers trust what they are being shown. Monthly management accounts should tie to practice software data, and any adjustments to EBITDA should be easy to support with documentation.
Segment revenue by payer type and treatment type. Track active patients, recall rates, plan income, and retention trends. Show which parts of the income base are stable and which are more variable. That level of preparation changes the tone of a transaction: it gives buyers fewer reasons to reduce their offer or insert protective deal terms.
The Exit Readiness Scorecard is a useful starting point to identify where your practice stands today and what needs attention before you engage the market. For a broader view of what drives value across UK businesses, the Valuation Insights Vault covers exit planning, EBITDA multiples, and due diligence in detail.
What This Means for Your Practice
A dental practice is worth more when future cash flow looks believable. Turnover may open the conversation, but retention, repeat care, and maintainable EBITDA tend to settle the price.
Principals who focus now on patient retention, hygiene demand, clean management data, and a less owner-dependent model will enter a sale process from a considerably stronger position than those who leave it to the last moment.
If you want a valuation that stands up to buyer and lender scrutiny, rather than one that unravels during due diligence, contact Consult EFC to discuss what your practice is genuinely worth and what you can do to improve it before you go to market.
Get a dental practice valuation that holds up under scrutiny
Consult EFC delivers ICAEW-grade business valuations for UK dental practices. EBITDA normalisation, sector-calibrated multiples, and comparable transaction analysis, delivered personally by Kishen Patel with no junior analysts involved. Fixed fees. 7 to 10-day turnaround.
- Full normalised EBITDA review and add-back analysis
- NHS, mixed, and private practice comparables
- Lender-ready and buyer-ready report format
- HMRC SAV compliant for share transfers and EMI schemes
Confidential · No obligation · Response within one business day · Contact Us
Not sure what your business is worth right now?
Request a confidential valuation — ICAEW Chartered Accountants, Big Four trained. No junior analysts. Fixed fees.
Request My Valuation